Related Experiment Video
Updated: Jun 2, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Using ECT in schizophrenia: a review from a clinical perspective.
Iannis M Zervas1, Christos Theleritis, Costantin R Soldatos
1Department of Psychiatry, Athens University Medical School, Athens, Greece. zerian@vivodinet.gr
Summary
Electroconvulsive therapy (ECT) can significantly benefit certain schizophrenia patients, particularly those with catatonia and positive symptoms. Combining ECT with medication, especially clozapine, appears most effective for treatment-resistant schizophrenia.
Area of Science:
- Psychiatry
- Neurology
- Pharmacology
Background:
- Clinical use of Electroconvulsive Therapy (ECT) in schizophrenia is not well-defined.
- Current application relies heavily on data from depression studies.
- Specific questions regarding ECT's efficacy in schizophrenia remain unanswered.
Purpose of the Study:
- To review existing data on ECT use in schizophrenic patients.
- To focus on symptom response, technical aspects, maintenance ECT, and medication combinations.
- To clarify the clinical utility of ECT for schizophrenia.
Main Methods:
- Systematic review of original studies found via PubMed.
- Inclusion of data from recent and older expert reviews.
- Analysis focused on four key areas: symptom response, technical application, continuation/maintenance ECT, and combination with medication.
Main Results:
- Catatonic schizophrenia shows the highest responsiveness to ECT.
- Positive symptoms (e.g., paranoid delusions) and affective symptoms also respond.
- ECT may enhance medication responsiveness.
- Longer ECT courses may be beneficial, except for catatonia.
- Combination therapy, particularly with clozapine, is more effective than monotherapy.
- Continuation and maintenance ECT appear beneficial for responders.
Conclusions:
- Electroconvulsive therapy (ECT) offers significant benefits for select schizophrenia patients.
- Further research is needed to address specific clinical questions regarding ECT in schizophrenia.
- Optimizing ECT protocols and combination therapies is crucial.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...